# Lee Duncan Cranmer, MD PhD – FDA Inspection, Sep 6, 2024

Source: https://www.keypedia.com/records/fda_inspections/lee-duncan-cranmer-md-phd/f99fefc7-dd3a-4955-b16f-8b7283f1336b
Source feed: FDA_Inspections

> FDA inspection 1248875 of Lee Duncan Cranmer, MD PhD, September 06, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1248875
- Company Name: Lee Duncan Cranmer, MD PhD
- Inspection Date: 2024-09-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Seattle District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 765224 - 2012-01-06

## Related Officers

- [Investigator](https://www.keypedia.com/people/alanna-l-mussawwir-bias/1283ff1a-34dd-4d90-9389-7bff2570527d)

Company: https://www.keypedia.com/companies/lee-duncan-cranmer-md-phd/21b3d8a0-bac3-4673-882f-cb974d25cf2f

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913